134.63

0.93% -1.3158

Agilent Technologies Inc (A)

Overview News Price History Option Chain Financials Why A Down? Discussions Forecast Stock Split Dividend History

Agilent Technologies Inc stock is traded at $134.63, with a volume of 232.23K. It is down -0.93% in the last 24 hours and down -2.68% over the past month. Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Previous Close:

$135.95

Open:

$135.395

24h Volume:

232.23K

Relative Volume:

0.12

Market Cap:

$38.17B

Revenue:

$6.95B

Net Income/Loss:

$1.30B

P/E Ratio:

29.46

EPS:

4.5696

Net Cash Flow:

$1.15B

1W Performance:

-3.64%

1M Performance:

-2.68%

6M Performance:

+12.67%

1Y Performance:

-10.42%

1-Day Range:

$134.07

$135.57

1-Week Range:

$133.96

$141.19

52-Week Range:

$96.43

$160.27

Agilent Technologies Inc Stock (A) Company Profile

Name

Agilent Technologies Inc

Sector

Healthcare (1119)

Industry

Diagnostics & Research (52)

Phone

(408) 345-8886

Address

5301 STEVENS CREEK BLVD, SANTA CLARA, CA

Employee

18,100

Twitter

@agilent

Next Earnings Date

2025-11-24

Latest SEC Filings

A's Discussions on Twitter

Compare A with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
A Agilent Technologies Inc	134.66	38.54B	6.95B	1.30B	1.15B	4.5696
TMO Thermo Fisher Scientific Inc	617.48	234.41B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	231.25	166.52B	24.27B	3.50B	5.02B	4.8589
IDXX Idexx Laboratories Inc	686.42	55.48B	4.17B	1.03B	940.22M	12.61
IQV Iqvia Holdings Inc	239.04	41.05B	15.90B	1.28B	2.21B	7.2842

Agilent Technologies Inc Stock (A) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-20-26	Initiated	HSBC Securities	Buy
Jan-05-26	Upgrade	Evercore ISI	In-line → Outperform
Dec-15-25	Upgrade	Barclays	Equal Weight → Overweight
Dec-09-25	Initiated	Goldman	Buy
Dec-02-25	Initiated	Morgan Stanley	Overweight
Oct-08-25	Initiated	Rothschild & Co Redburn	Buy
Oct-08-25	Upgrade	UBS	Neutral → Buy
Feb-10-25	Upgrade	Barclays	Underweight → Equal Weight
Aug-28-24	Initiated	Wells Fargo	Overweight
Jul-10-24	Upgrade	Citigroup	Neutral → Buy
Jun-27-24	Downgrade	Wolfe Research	Outperform → Peer Perform
Jun-03-24	Resumed	Jefferies	Hold
Apr-05-24	Upgrade	Stifel	Hold → Buy
Dec-13-23	Initiated	Wolfe Research	Outperform
Dec-12-23	Downgrade	BofA Securities	Buy → Neutral
Nov-17-23	Downgrade	UBS	Buy → Neutral
Sep-28-23	Initiated	Bernstein	Mkt Perform
Jul-31-23	Downgrade	Evercore ISI	Outperform → In-line
May-24-23	Reiterated	Barclays	Equal Weight
May-24-23	Reiterated	BofA Securities	Buy
May-24-23	Reiterated	Citigroup	Neutral
May-24-23	Reiterated	Credit Suisse	Outperform
May-24-23	Reiterated	Evercore ISI	Outperform
May-24-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-24-23	Reiterated	Robert W. Baird	Outperform
May-24-23	Reiterated	SVB Securities	Outperform
May-24-23	Reiterated	Stifel	Hold
May-24-23	Reiterated	TD Cowen	Outperform
May-24-23	Reiterated	Wells Fargo	Overweight
May-11-23	Initiated	Barclays	Equal Weight
Jan-10-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Aug-25-22	Initiated	Credit Suisse	Outperform
Jul-20-22	Initiated	UBS	Buy
Jul-08-22	Downgrade	Citigroup	Buy → Neutral
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Feb-23-22	Reiterated	BofA Securities	Buy
Feb-23-22	Reiterated	Citigroup	Buy
Feb-23-22	Reiterated	Cowen	Outperform
Feb-23-22	Reiterated	Evercore ISI	Outperform
Feb-23-22	Reiterated	Stifel	Hold
Feb-23-22	Reiterated	Wells Fargo	Overweight
Nov-23-21	Reiterated	BofA Securities	Buy
Nov-23-21	Reiterated	Cowen	Outperform
Nov-23-21	Reiterated	Stifel	Hold
Mar-18-21	Upgrade	Citigroup	Neutral → Buy
Feb-17-21	Upgrade	BofA Securities	Neutral → Buy
Dec-02-20	Initiated	Goldman	Buy
Nov-25-20	Upgrade	UBS	Neutral → Buy
Nov-17-20	Upgrade	Cleveland Research	Neutral → Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Sep-30-20	Initiated	Atlantic Equities	Neutral
Aug-19-20	Reiterated	BofA Securities	Neutral
Aug-19-20	Reiterated	Citigroup	Neutral
Aug-19-20	Reiterated	Jefferies	Buy
Aug-19-20	Reiterated	Robert W. Baird	Outperform
Aug-19-20	Reiterated	SVB Leerink	Outperform
Aug-19-20	Reiterated	Stifel	Hold
Aug-19-20	Reiterated	Wells Fargo	Overweight
Feb-24-20	Downgrade	Needham	Buy → Hold
Jan-08-20	Initiated	Wells Fargo	Overweight
Jan-07-20	Initiated	Citigroup	Neutral
Nov-26-19	Reiterated	Needham	Buy
Nov-15-19	Initiated	Stifel	Hold
Oct-18-19	Downgrade	UBS	Buy → Neutral
Jul-16-19	Downgrade	BofA/Merrill	Buy → Neutral
Jul-15-19	Downgrade	Barclays	Overweight → Equal Weight

View All

Agilent Technologies Inc Stock (A) Latest News

Jan 27, 2026

Published on: 2026-01-28 11:41:14 - baoquankhu1.vn

Jan 27, 2026

ETF Watch: Is Agilent Technologies Inc impacted by rising rates2025 Big Picture & Fast Momentum Entry Tips - baoquankhu1.vn

Jan 27, 2026

Jan 26, 2026

Microarrays Market Size to Accumulate Around USD 10.72 Billion by 2033, Driven by Expanding Genomics Research and Advanced Diagnostic Adoption – SNS Insider - GlobeNewswire Inc.

Jan 26, 2026